Stock screenerAll disclosures →
EDGAR →
RGNX
Conviction 73HealthcareScan · Fri, Jul 17, 2026RGNX$9.87-11.92%
ResistanceSupportVol 14Insider sellVol MA14 3.42M
Apr 17May 5May 22Jun 10Jun 30Jul 17
Price9.87
Change-11.92%
Gap-20.18%
Rel volume5.02×
Avg volume3.57M
Avg $ vol40.65M
SMA 2012.04
SMA 509.17
SMA 20010.61
Price vs 50+7.63%
Price vs 200-7.03%
MA stackmixed
50/200 cross—
Supertrenddown · 13.32
RSI (14)42
MACD hist-0.47
MACD crossbear · 2d
Stoch %K / %D19 / 27
ADX (14)38
+DI / −DI22 / 35
RSI divergence—
MACD divergence—
ATR %+12.44%
ADR %10.48%
52w high15.98
52w low5.65
From 52w high-38.27%
Above 52w low+74.60%
New 52w highNo
SqueezeOff
Bollinger width71.81%
%B0.25
Donchian pos25.74%
Donchian high15.88
Donchian low7.78
AVWAP (52w high)9.40
vs AVWAP high+4.93%
AVWAP (52w low)9.67
vs AVWAP low+2.06%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d5.02×
Avg vol (14d)3.42M
Avg vol (20d)3.57M
Avg $ vol (20d)40.65M
Market cap510M
RS 3m (vs SPY)+12.40%
RS 6m (vs SPY)-33.79%
RS line new highNo
Trend template4/8
Technical rank39.9
1 week-29.28%
1 month+42.35%
3 months+7.34%
6 months-34.01%
1 year+16.06%
YTD-27.30%
P/E-2.63
P/B24.19
P/S2.99
P/FCF-4.04
EPS-3.76
Div yield—
ROE-919.64%
ROA-56.71%
Debt/Eq—
Current2.62
EV/EBITDA-3.40
Gross margin—
Net margin-113.75%
Rev growth104.54%
EPS growth14.63%
Price target20.89
Target upside111.76%
Analyst ratingBuy
Institutional87.29%
Ent. value494.77M
Revenue6.39M
Net income-90.05M
Gross profit—
Free cash flow-126.38M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out51.7M
Employees371
ListedThu, Sep 17, 2015
Free float38.66M
Float %74.9%
Short interest10.46M
Days to cover3.2d
Short volume26.4%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.72 vs −$1.36
Last surprise-26.5% miss
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank39.9 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance13.43
Support5.92
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RGNX
No recent disclosed trades by Congress in RGNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RGNX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bennett Jean Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Tasse Daniel Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Zachary Jennifer Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Glucksmann Alexandra Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
KARABELAS ARGERIS N Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Glucksmann Alexandra Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Tasse Daniel Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Zachary Jennifer Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Fox Allan M. Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
KARABELAS ARGERIS N Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in RGNX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.